作者: Hinrich Gronemeyer , Michel Lanotte , Gérard Benoit , Marco Gottardis
DOI:
关键词: Internal medicine 、 Endocrinology 、 Pharmacology 、 Agonist 、 Protein kinase A 、 Chemistry 、 Retinoid X receptor
摘要: The invention relates to compositions comprising a retinoid X receptor agonist and an agent capable of activating protein kinase A. also methods treating hyperproliferative diseases by administering